- Rasagiline, sold
under the
brand name
Azilect among others, is a
medication which is used in the
treatment of Parkinson's disease. It is used as a monotherapy...
- (Pirazidol) (available in Russia)
Selective MAO-B
inhibitors Rasagiline (
Azilect)
Selegiline (Deprenyl, Eldepryl, Emsam, Zelapar)
Safinamide (Xadago) Linezolid...
-
monoamine oxidase (MAO) B
inhibitors l-deprenyl (Selegiline) and
rasagiline (
Azilect) as anti-Parkinson
drugs which possess neuroprotective activities. He is...
- Yosipovitch, Gil (June 2012). "Livedo
Reticularis ****ociated With
Rasagiline (
Azilect)".
Journal of
Drugs in Dermatology. 11 (6): 764–5. PMID 22648227. Archived...
-
treatment of
multiple sclerosis), now the world's best
selling MS drug, and
Azilect (sold as
Agilect in some countries) for
treatment of Parkinson's disease...
- of
novel cell-based
immunotherapy for
various cancers.
Development of
Azilect, a drug for Parkinson's disease, by
Moussa Youdim and John
Finberg from...
-
Youdim developed Rasagiline, a drug
marketed by Teva
Pharmaceuticals as
Azilect (TM) for the
treatment of
neurodegenerative disease,
especially Parkinson's...
- il.
Archived from the
original on 21 July 2011.
Retrieved 16 May 2017. "
AZILECT® (rasagiline tablets), 0.5 and 1 mg".
Daily Med.
United States National...
-
Ozanimod (Zeposia) – sphingosine-1-phosphate
receptor agonist Rasagiline (
Azilect; N-propargyl-(R)-1-aminoindane) –
selective irreversible MAO-B inhibitor...
- Indole-5-carboxamides
Selegiline (Eldepryl, Zelapar, Emsam)
Rasagiline (
Azilect)
Monoamine oxidase A GRCh38:
Ensembl release 89: ENSG00000069535 – Ensembl...
